Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease

Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance

(2012) Matthew J. Hamilton et al.   JOURNAL OF GASTROENTEROLOGY

Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease

(2011) T. Aomatsu et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

(2011) Alan W Walker et al.   BMC MICROBIOLOGY

Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease

(2011) Tomoki Aomatsu et al.   DIGESTIVE DISEASES AND SCIENCES

Digesting the genetics of inflammatory bowel disease: Insights from studies of autophagy risk genes

(2011) Amrita Kabi et al.   INFLAMMATORY BOWEL DISEASES

Role of the microbiota in inflammatory bowel diseases

(2011) Nabeetha A. Nagalingam et al.   INFLAMMATORY BOWEL DISEASES

Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis

(2011) Akira Andoh et al.   JOURNAL OF GASTROENTEROLOGY

A Computer-assisted Model for Predicting Probability of Dying Within 7 Days of Hospice Admission in Patients with Terminal Cancer

(2010) J. K. Chiang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

(2010) C. De Filippo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

(2010) K. Atarashi et al.   SCIENCE

Recent Advances in Molecular Approaches to Gut Microbiota in Inflammatory Bowel Disease

(2009) Akira Andoh et al.   CURRENT PHARMACEUTICAL DESIGN

Low counts of Faecalibacterium prausnitzii in colitis microbiota

(2009) H. Sokol et al.   INFLAMMATORY BOWEL DISEASES

Evolving paradigms in the pathogenesis of IBD

(2009) Lloyd Mayer   JOURNAL OF GASTROENTEROLOGY

Faecal microbiota profile of Crohn’s disease determined by terminal restriction fragment length polymorphism analysis

(2008) A. ANDOH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Advances in the use of terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes to characterize microbial communities

(2008) Ursel M. E. Schütte et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Microbial Influences in Inflammatory Bowel Diseases

(2008) R. Balfour Sartor   GASTROENTEROLOGY

Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune Responses

(2008) Jason A. Hall et al.   IMMUNITY

Inflammatory bowel disease, past, present and future: lessons from animal models

(2008) Atsushi Mizoguchi et al.   JOURNAL OF GASTROENTEROLOGY

A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells

(2008) Ken Cadwell et al.   NATURE

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis

(2008) Jun Nishikawa et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY